Rush: Augmenting Drug Discovery with Machine-Driven
Superintelligence
Rush is an AI-powered drug discovery platform accessible to all
scientists, using machine learning and computational chemistry.
Accelerate your pharmaceutical research with intelligent molecular
design, virtual screening, and predictive analytics. Free tier
available.
Find and Evaluate Hits
-
Structure Prediction: Predict the 3D structure of
biological molecules and their interactions — from individual
protein folding to protein-protein, protein-peptide, and
protein-ligand complexes.
-
Binding Site Prediction: Identify potential
ligand-binding pockets on a protein surface using structure-based
methods.
-
Virtual Screening: Quickly and cost-effectively
evaluate hundreds of thousands of compounds against a biological
target using computational models to identify promising candidates
before lab testing.
-
Molecular Docking: Predict how a molecule will
fit and interact within a protein's binding site, revealing
potential binding strength and orientation.
-
Super Accurate Binding Affinity: Leverage quantum
mechanical calculations to precisely estimate how strongly a
molecule binds to its target, improving hit prioritization and
lead selection.
Understand and Predict Activity
-
Patent SAR Extraction: Automatically mine patents
and papers for structure-activity relationship (SAR) data, turning
buried chemical insights into structured, searchable knowledge.
-
SAR Analysis: Analyze structure-activity
relationship (SAR) data to uncover trends between chemical
structure and biological activity, guiding lead optimization.
-
QSAR, Property Prediction, and Optimisation: Use
quantitative structure-activity relationship models to forecast
how structural changes influence a molecule's activity, and
predict key properties to guide optimisation for potency, safety,
and drug-likeness.
-
QM/MM Simulation: Combine quantum mechanics and
molecular mechanics to accurately model chemical reactions or
binding events at an atomic level within complex biological
systems.
Design New Chemistry
-
Small Molecule Generation: Explore chemical space
by generating novel compounds similar in structure to a chosen
reference molecule.
-
Small Molecule Similarity Search: Find
purchasable compounds with similar structures to a reference
compound, uncovering potential analogs.
-
Automated Bioisostere Enumeration: Systematically
swap parts of a molecule with known bioisosteric replacements —
generating smart analogs that maintain activity while exploring
new chemical space, improving potency, selectivity, or drug-like
properties.
Why Choose Rush?
Rush speeds up all drug discovery researchers by combining
cutting-edge artificial intelligence with user-friendly interfaces,
making advanced computational chemistry tools accessible, automating
important drug discovery workflows, and unlocking new capabilities.
Rush is also the only way to access QDX's world record breaking
quantum chemistry software - faster and larger than anything else by
1000x.
Our platform integrates state-of-the-art computational tools with an
AI assistant, enabling scientists to accelerate their research
without requiring computational expertise. Whether you're exploring
new therapeutic targets, optimizing lead compounds, or predicting
drug interactions, Rush provides the tools you need to make
breakthrough discoveries in preclinical small molecule pipelines.
Create your free account today and experience the future of
pharmaceutical research.
Get started with Rush and transform your drug discovery workflow
with the power of AI.